133 related articles for article (PubMed ID: 33626970)
41. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
42. The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department.
Tan BCH; Tang I; Bonin J; Koelmeyer R; Hoi A
Rheumatology (Oxford); 2022 Nov; 61(11):4509-4513. PubMed ID: 35348630
[TBL] [Abstract][Full Text] [Related]
43. Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region.
Vilar MJ; Bezerra EL; Sato EI
Clin Rheumatol; 2005 Aug; 24(4):377-80. PubMed ID: 15599643
[TBL] [Abstract][Full Text] [Related]
44. The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients.
Pitta AC; Silva CA; Insfrán CE; Pasoto SG; Trindade VC; Novak GV; Sakamoto AP; Terreri MT; Pereira RM; Magalhães CS; Fonseca AR; Islabão AG; Assad AP; Buscatti IM; Elias AM; Piotto DP; Ferriani VP; Carvalho LM; Rabelo Junior CN; Marini R; Sztajnbok FR; Sacchetti SB; Bica BE; Moraes AJ; Robazzi TC; Lotufo S; Cavalcanti AS; Naka EN; Carneiro-Sampaio M; Bonfá E; Aikawa NE;
Lupus; 2021 Dec; 30(14):2286-2291. PubMed ID: 34689652
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
[TBL] [Abstract][Full Text] [Related]
46. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities.
Johnson SR; Brinks R; Costenbader KH; Daikh D; Mosca M; Ramsey-Goldman R; Smolen JS; Wofsy D; Boumpas DT; Kamen DL; Jayne D; Cervera R; Costedoat-Chalumeau N; Diamond B; Gladman DD; Hahn B; Hiepe F; Jacobsen S; Khanna D; Lerstrøm K; Massarotti E; McCune J; Ruiz-Irastorza G; Sanchez-Guerrero J; Schneider M; Urowitz M; Bertsias G; Hoyer BF; Leuchten N; Tani C; Tedeschi SK; Touma Z; Schmajuk G; Anic B; Assan F; Chan TM; Clarke AE; Crow MK; Czirják L; Doria A; Graninger WB; Halda-Kiss B; Hasni S; Izmirly PM; Jung M; Kumánovics G; Mariette X; Padjen I; Pego-Reigosa JM; Romero-Diaz J; Rúa-Figueroa Í; Seror R; Stummvoll GH; Tanaka Y; Tektonidou MG; Vasconcelos C; Vital EM; Wallace DJ; Yavuz S; Meroni PL; Fritzler MJ; Naden R; Dörner T; Aringer M
Ann Rheum Dis; 2020 Oct; 79(10):1333-1339. PubMed ID: 32816709
[TBL] [Abstract][Full Text] [Related]
47. New classification criteria for systemic lupus erythematosus correlate with disease activity.
Anić F; Zuvić-Butorac M; Stimac D; Novak S
Croat Med J; 2014 Oct; 55(5):514-9. PubMed ID: 25358884
[TBL] [Abstract][Full Text] [Related]
48. Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE).
Raman L; Yahya F; Ng CM; Sockalingam S; Ramasamy K; Ratnam R; Raja J
Lupus; 2020 Dec; 29(14):1885-1891. PubMed ID: 33040647
[TBL] [Abstract][Full Text] [Related]
49. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
50. Multimorbidity in systemic lupus erythematosus in a population-based cohort: the lupus Midwest network.
Figueroa-Parra G; Meade-Aguilar JA; Hulshizer CA; Gunderson TM; Chamberlain AM; Thanarajasingam U; Greenlund KJ; Barbour KE; Crowson CS; Duarte-García A
Rheumatology (Oxford); 2023 Nov; ():. PubMed ID: 38001025
[TBL] [Abstract][Full Text] [Related]
51. Classifying systemic lupus erythematosus using laboratory items alone: a preliminary study.
Zhang L; Ma J; Yan D; Liu Z; Xue L
Clin Rheumatol; 2024 Mar; 43(3):1037-1043. PubMed ID: 38342796
[TBL] [Abstract][Full Text] [Related]
52. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Tarr T; Papp G; Nagy N; Cserép E; Zeher M
Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
[TBL] [Abstract][Full Text] [Related]
53. Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease.
Drehmel KR; Erickson AR; England BR; Michaud KD; Sayles HR; Hearth-Holmes MP
Lupus; 2021 Feb; 30(2):280-284. PubMed ID: 33252299
[TBL] [Abstract][Full Text] [Related]
54. Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features.
Cosatti MA; Muñoz S; Alba P; Helling CA; Roverano S; Sarano J; Malm-Green S; Danielsen M; Medina Bornachera D; Alvarez A; Eimon A; Pendón G; Mayer M; Marin J; Catoggio C; Pisoni CN
Lupus; 2018 Jan; 27(1):33-39. PubMed ID: 28385125
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-Based Registry.
Guttmann A; Denvir B; Aringer M; Buyon JP; Belmont HM; Sahl S; Salmon JE; Askanase A; Bathon JM; Geraldino-Pardilla L; Ali Y; Ginzler EM; Putterman C; Gordon C; Helmick CG; Parton H; Izmirly PM
Arthritis Care Res (Hoboken); 2023 May; 75(5):1007-1016. PubMed ID: 35638708
[TBL] [Abstract][Full Text] [Related]
56. [Cumulative organ damage evaluation using SLICC/ACR-DI in patients with more than five years of systemic lupus erythematosus].
Sella EM; Sato EI
Rev Bras Reumatol; 2004 Apr; 44(2):115-22. PubMed ID: 21503536
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
Tarazi M; Gaffney RG; Kushner CJ; Chakka S; Werth VP
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1404-1409. PubMed ID: 31058462
[TBL] [Abstract][Full Text] [Related]
58. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
59. Slicc damage index score in systemic lupus erythematosus patients and its associated factors.
Ghazali WSW; Daud SMM; Mohammad N; Wong KK
Medicine (Baltimore); 2018 Oct; 97(42):e12787. PubMed ID: 30334968
[TBL] [Abstract][Full Text] [Related]
60. Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
Johnson SR; Gladman DD; Brunner HI; Isenberg D; Clarke AE; Barber MRW; Arnaud L; Fortin PR; Mosca M; Voskuyl AE; Manzi S; Aranow C; Askanase A; Alarcón GS; Bae SC; Costedoat-Chalumeau N; English JA; Pons-Estel GJ; Pons-Estel BA; Gilman R; Ginzler EM; Hanly JG; Jacobsen S; Kalunian K; Kamen DL; Lambalgen C; Legge A; Lim SS; Mak A; Morand EF; Peschken CA; Petri M; Rahman A; Ramsey-Goldman R; Reynolds JA; Romero-Diaz J; Ruiz-Irastorza G; Sanchez-Guerrero J; Svenungsson E; Touma Z; Urowitz M; Vinet E; van Vollenhoven RF; Waldhauser H; Wallace DJ; Zoma A; Bruce IN
Arthritis Care Res (Hoboken); 2023 May; 75(5):998-1006. PubMed ID: 34962100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
